Prevalence of Hepatitis C Virus Infection Among Injecting Drug Users in Glasgow 1990–1996: are Current Harm Reduction Strategies Working?

Objectives: To determine the prevalence of HCV antibodies among injecting drug users and to gauge the effectiveness of needle/syringe exchange in preventing the transmission of HCV infection. Methods: Between 1990–1994 and in 1996, annual cross-sectional surveys of injecting drug users in Glasgow we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infection 2000-03, Vol.40 (2), p.176-183
Hauptverfasser: Taylor, A., Goldberg, D., Hutchinson, S., Cameron, S., Gore, S.M., McMenamin, J., Green, S., Pithie, A., Fox, R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives: To determine the prevalence of HCV antibodies among injecting drug users and to gauge the effectiveness of needle/syringe exchange in preventing the transmission of HCV infection. Methods: Between 1990–1994 and in 1996, annual cross-sectional surveys of injecting drug users in Glasgow were conducted. In order to ensure as representative a sample as possible, the 1949 respondents were recruited from both ‘in-treatment’ and ‘out-of treatment’ settings. Injectors were interviewed about their risk behaviours for blood-borne viruses and provided a saliva sample which was initially tested, anonymously, for HIV antibodies, and subsequently tested for hepatitis C infection. Results: Among 1949 injectors, the prevalence of salivary antibodies, indicative of hepatitis C viraemia, was 61% (95% confidence interval (CI) 59%–63%): the estimated prevalence of serum antibody positivity was 72%. Length of injecting, year of commencing drug injecting and the number of times in prison were predictive of antibody positivity. Thirty-one per cent of injectors who commenced their injecting after 1992, following the full establishment of needle/syringe exchange in the city, were salivary antibody positive, and the majority of their infections were acquired outside the prison setting. Respondents who began injecting after the introduction of needle/syringe exchange in the city were significantly less likely to test HCV antibody positive than those who commenced injecting prior to the advent of needle/syringe exchange, after adjusting for length of injecting career. Conclusion: The prevalence of HCV among injectors in Glasgow has decreased during the era of needle/syringe exchange. However, there is evidence to suggest that the incidence of infection remains high. Since the prevalence of hepatitis C viraemia among the city's injecting population is extremely high, ongoing transmission is inevitable unless more effective interventions are identified and implemented urgently.
ISSN:0163-4453
1532-2742
DOI:10.1053/jinf.2000.0647